
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
WebsitePrice
Market cap
Next catalystExpected Q4 2026TEV-’408 — planned seamless vitiligo Phase 2b/3 · Trial initiationCompany release ↗
Cash
Chart & Events
Core Clinical
PreINDP1P2P3FilingApproved
PreINDP1P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
Other pipelines
Partner / License out
PreINDP2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Approved / commercial
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
History / paused
TEVA PR & News
PR & News
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA PHARMACEUTICAL INDUSTRIES LTD